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The present work aims to assess the antibacterial potential of phenolic extracts, recovered from plants obtained on the North East
of Portugal, and of their phenolic compounds (ellagic, caffeic, and gallic acids, quercetin, kaempferol, and rutin), against bacteria
commonly found on skin infections. The disk diffusion and the susceptibility assays were used to identify the most active extracts
and phenolic compounds. The effect of selected phenolic compounds on animal cells was assessed by determination of cellular
metabolic activity. Gallic acid had a higher activity, against gram-positive (S. epidermidis and S. aureus) and gram-negative bacteria
(K. pneumoniae) at lower concentrations, than the other compounds. The caffeic acid, also, showed good antibacterial activity
against the 3 bacteria used. The gallic acid was effective against the 3 bacteria without causing harm to the animal cells. Gallic and
caffeic acid showed a promising applicability as antibacterial agents for the treatment of infected wounds.
1. Introduction
Skin, the largest human organ, works as a mechanical barrier
against environment hazards and is, also, responsible for self-
healing, immune surveillance, sensor detection, thermoreg-
ulation, and fluid homeostasis [1, 2]. Injuries, caused by
extreme temperature, trauma, chronic ulcerations, pressure,
or venous stasis, promote disruption of skin integrity allow-
ing the deposition and colonisation of the injury tissue by a
wide range of bacteria [3]. Skin and soft tissues infections are
typically associated with staphylococci or streptococci, but
virtually anymicroorganismmay induce tissue inflammation
and immune response [4, 5]. The severity of these infec-
tions may range from self-limit superficial infections to life-
threatening diseases. The most common treatment is the use
of broad-spectrum antibiotics. However, the indiscriminate
use of this kind of drugs affects the normal skin flora andmay
result in multiresistant strains [6]. In order to overcome this
issue it is critical to identify new antimicrobial agents.
Plants are a viable, unlimited source of bioactive
molecules, including antimicrobial agents which protect
them from microorganism, insects, and predators [7–11].
Phenolic compounds belong to these bioactive molecules’
group; their pharmaceutical properties and benefits for
human health have been demonstrated in several pub-
lished studies [7, 8]. Anti-inflammatory, antioxidant, and
antimicrobial are some of the properties attributed to those
molecules [7, 8].
The northeastern region of Portugal, Tra´s-os-Montes,
gathers awide range ofwild plants used on folk pharmacopeia
and traditional cuisine. Several ethnobotanical surveys con-
ducted in this region byMountain Research Centre (CIMO)-
ESA, Polytechnic Institute of Braganc¸a, selected some of
these wild plants as potential source of natural antimicrobial
agents.
The present work aims to select phenolic compounds
identified on extracts of selected wild plants from north-
eastern region of Portugal to be applied as antibacterial
agents on the treatment of infected wounds.The antibacterial
activity of 8 phenolic extracts and 6 phenolic compounds
was tested against Staphylococcus epidermidis, Staphylococcus
aureus, and Klebsiella pneumoniae, usually associated with
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skin and soft tissue infections. The influence of the most
effective phenolic compounds on human fibroblasts was, also,
evaluated.
2. Material and Methods
2.1. Phenolic Extracts and Compounds. The plant samples
and their phenolic extracts were obtained as described by
Barros:Asparagus acutifolius (shoots), Aa, and Bryonia dioica
(young stems), Bd [12];Cytisus multiflorus (flowers), Cm, and
Sambucus nigra (flowers), Sn, [13]; Rosa micrantha (flowers),
Rm, Filipendula ulmaria (inflorescences), Fu, and Castanea
sativa (upright catkins during anthesis), Cs [14]; and Cistus
ladanifer (leaves), Cl [15]. The phenolic characterization of
the extracts is also described on the publications mentioned
above. Six different phenolic compounds, recovered from
those plants, were pointed out as the main ones: 3 phenolic
acids (caffeic, ellagic and gallic acids) and 3 flavonoids
(kaempferol, quercetin and rutin) [12–15].
2.2. Strains and Growth Conditions. The antibacterial activity
of the phenolic extracts and compounds was tested against 3
bacteria: Staphylococcus epidermidis (ATCC 12228), Staphy-
lococcus aureus (ATCC 6538), and Klebsiella pneumoniae
(ATCC 11296). The bacteria were grown in tryptic soy agar
(TSA, Merck, Germany) for 24 h at 37∘C. The cells were
inoculated in tryptic soy broth (TSB, Merck, Germany)
and incubated for 18 h at 37∘C under agitation (120 rpm).
Subsequently, bacterial concentration of each strain was
adjusted to 1 × 106 cells⋅mL−1, via absorbance readings and
the corresponding calibration curve.
2.3. Disk Diffusion Assay. The antibacterial activity of the
extracts or compounds against the 3 bacteria was assessed,
first, by the disc diffusion method described by the National
Committee for Clinical Laboratory Standards (NCCLS), M2-
A8 document [16], with some modifications. The TSA was
the nutritive media used and it was prepared according to
the instructions of the manufacturer. Afterwards, 200𝜇L of
each inoculum (1 × 106 cells⋅mL−1) was spread on the solid
media plates (90mm Petri dishes). Sterile filter paper disks
(“Blank Discs,” Liofilchem, Roseto, Italy, 6mm in diameter)
were placed over the petri dish and impregnatedwith 20𝜇L of
each extract (200mg⋅mL−1) or compounds (5mg⋅mL−1).The
plates were incubated at 37∘C for 24 h. Thereafter, the size of
the halo from the inhibition growth was measured.
2.4. Susceptibility Assay: Minimal Inhibitory Concentration
(MIC) and Minimal Bactericidal Concentration (MBC). MIC
and MBC were obtained according to the method described
by Wiegand et al. [17], an adaptation of the standard method
published by Clinical and Laboratory Standards Institute
(CLSI) and the European Committee on Antimicrobial Sus-
ceptibility Testing (EUCAST) [18], using the brothmicrodilu-
tion procedure. Thus, a work solution of 20mg⋅mL−1 of each
extract and 10mg⋅mL−1 of each compound were prepared in
sterile distilled water. The 96-well plate (Orange Scientific,
Braine-l’ Alleud, Belgium)was prepared by adding 100 𝜇L of a
solution of each extract/compound to a final concentration of
20mg⋅mL−1/10mg⋅mL−1 to the firstwell.Then serial dilutions
(1 : 10) were made with MHB (Mueller-Hinton broth, Merck,
Germany) in the other wells, to final volume of 50 𝜇L. At
each well, 50𝜇L of each bacteriumwas added (S. epidermidis,
S. aureus, and K. pneumoniae). The extracts concentration
tested ranged between 0.02 and 10mg⋅mL−1 and the phenolic
compounds from 0.01 to 5mg⋅mL−1. Drug-free and bacteria
controls were also included. The plates were incubated for
24 h at 37∘C.
TheMIC value was determined by the observation of the
concentration that did not show any growth, by contrast with
the bacteria control. The MBC, number of viable cells, was
assessed by determination of the number of colony forming
units (CFUs). The CFUs were measured by plating 10 𝜇L of
cell suspension from each well onto TSA and incubated for
24 h at 37∘C.
The procedure was made in triplicate for each extract,
compound and bacteria combination, in, at least, 3 indepen-
dent assays.
2.5. Cytotoxicity Determination. Fibroblast 3T3 (CCL 163)
from American Type Culture Collection was used in this
study. Cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% of foetal bovine
serum and 1% penicillin/streptomycin at 37∘C, 5%CO
2
. After
achieving the confluence, cells were passed at the density of 1
× 105 cells⋅mL−1, using trypsin.
To assess the effect of the compounds on the cellular via-
bility, the cells were seeded at the density of 5 × 105 cells⋅mL−1
(24 well plate) in 1mL of DMEM complete medium. After
24 h, the medium was replaced by 500 𝜇L of fresh one and
500𝜇L of compounds, at twofold of the desired concentra-
tions dissolved in PBS. The plates were incubated for 24 h at
37∘C and 5%CO
2
. Afterwards, themediumwas removed and
a mixture of 20𝜇L of MTS [3-(4,5-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium] (Promega) and 980𝜇L of
DMEMwithout phenol was added to each well. After 1 h, the
absorbance value was measured at 490 nm and the results
were expressed as percentage of viable cells (%), using the
number of cells grown on wells without compounds as
controls.
The procedure wasmade in triplicate for each compound,
at least, in 3 independent assays.
3. Results and Discussion
The emergence of multiresistant strains of pathogenic and
opportunistic bacteria is correlated with the widespread use
of broad-spectrum antibiotics for treatment of skin and soft
tissue infections. Therefore, the search for new drugs and
new sources of antibacterial agents is of outmost importance
[19]. Natural sources, such as plants, have been explored and
gained prominence, since they offer many advantages when
compared to the synthetic ones. For instance, they show high
levels of biocompatibility and availability and low toxicity [7–
10]. Currently, polyphenolics are the major group of interest
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in view of their anti-inflammatory, antimicrobial, antiviral,
and antioxidant properties [20].
The antibacterial activity of phenolic extracts, from
medicinal Portuguese plants, and, also, of polyphenolic com-
pounds, identified on those extracts, was assessed by both
qualitative and quantitativemethods.The disk diffusion assay
is a qualitative method, which allows a first screening of the
potential antibacterial agents. However, this method presents
some issues regarding the capacity of the active molecules to
diffuse into the agar, and so, a quantitative method such as
the MIC and MBC determination should be used in order to
obtainmore accurate results.TheMIC is defined as the lowest
concentration of the antibacterial agent that inhibits the
visible bacteria growth observed with unaided eye, and the
MBC is the minimal concentration of the antibacterial agent
required to destroy most of the viable bacteria (reduction
of 3 logs of growth) for a given set of conditions [21].
It is important to refer to the fact that the extracts and
compounds present some colouration, which may lead to
some misleading of the MIC values. Therefore, the MBC
determination is crucial for a complementary analysis of the
antibacterial properties of the phenolic extract/compounds
[19].
3.1. Antimicrobial Activity of the Extracts. A preliminary
assay using phenolic extracts of Portuguese medicinal plants
was made, in order to identify phenolic compounds from
those extracts. The chemical characterization of the phenolic
extracts was described in previous works [12–15]. Both quali-
tative and quantitative analysesweremade to the antibacterial
activity of 8 phenolic extracts. From those extracts, only 5 (Cs,
Cl, Cm, Fu, and Rm) were capable of reducing the growth of
the 3 bacteria used (Figure 1). These extracts were selected as
themost promising ones and theirMIC andMBCvalueswere
assessed.
Thus, these extracts were selected as the most promising
ones. As the disk diffusion assay is based on themeasurement
of the growth inhibition halo, which is dependent on the
antibacterial agent ability to diffuse trough agar, quantitative
complementary assays were also performed.
The MIC and MBC values revealed that the Cs and Cl
had a similar effect on the bacteria, being more effective
against K. pneumoniae and S. epidermidis (MIC and MBC
0.625mg⋅mL−1 (for both species)) and less effective against
S. aureus (MIC 1.25 and MBC 2.5mg⋅mL−1). The Fu and
Rm extracts, also, showed similar effect against the bacteria;
namely, 2.5mg⋅mL−1 was capable of reducing completely the
3 bacteria growth when exposed to these 2 extracts. Since
Cm phenolic extract had MIC and MBC values higher than
10mg⋅mL−1, this extract was not used for further analysis.
3.2. Antimicrobial Activity of the Phenolic Compounds.
Six phenolic compounds identified in the extracts of Cl
(ellagic acid, kaempferol, and gallic acid), Fu (caffeic acid,
kaempferol, rutin, and gallic acid), Cs (gallic acid and rutin),
and Rm (kaempferol) were selected for further analysis.
Those compounds are all polyphenolics and can be placed
into two groups: (1) phenolic acids and (2) flavonoids. Caffeic,
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Figure 1: Values of the halo dimension (disk diffusion assay)
for each extract (200mg⋅mL−1) for the 3 bacteria. The halo size
was calculated by deducting the size of the disk (0.6 cm). Aa: A.
acutifolius; Bd: B. dioica; CS: C. sativa; Cl: C. ladanife; Cm: C.
multiflorus; Fu: F. ulmaria; Rm: R. Micrantha; and Sn: S. nigra.
gallic, and ellagic acid belong to the first group and the
remaining compounds (kaempferol, quercetin, and rutin) fit
into the flavonoids group.
The disk diffusion assay of the phenolic compounds
(Figure 2) demonstrated that they can inhibit the growth of S.
epidermidis, with the gallic acid being the most efficient and
caffeic acid, rutin, and quercetin being the least efficient. The
compounds present a similar halo size against S. aureus with
the exception of ellagic acid that did not change the bacteria
growth. Gallic acid and caffeic acid were the only phenolic
compounds tested capable of inhibiting the Gram-negative
bacteria (K. pneumoniae). Due to the different and interesting
results of the compounds in the diffusion assay, it was decided
to determine the MIC and MBC of all of them (Table 1).
Flavonoids are a group of polyphenolic molecules from
plant source with many biological properties already studied
[22, 23].Theflavonoids antibacterial capacity is based on their
ability to complex with extracellular and soluble proteins
and to destroy the bacteria cell wall by interacting with
essential enzymes responsible for maintaining the stability
of this structure [7, 19]. However, in the conditions tested,
the flavonoids selected (kaempferol, quercetin, and rutin) had
no effect on the bacteria growth for concentrations under
5mg⋅mL−1.
Our results, similar to Penna’s [24], suggest that
kaempferol has no activity under 5mg⋅mL−1 against S.
aureus. Additionally, Fattouch et al. [25] showed that
kaempferol presented activity only at a concentration of
10mg⋅mL−1. Regarding quercetin antimicrobial activity,
El-Gammal and Mansour [26] described that its MIC for S.
aureus was 37 𝜇g⋅mL−1. Fattouch et al. [25] achieved a MIC
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Table 1: MIC and MBC of the selected compounds for each of the bacteria (5 × 105 cells⋅mL−1).
(mg⋅mL−1) Chemical structure
S. epidermidis S. aureus K. pneumoniae
MIC MBC MIC MBC MIC MBC
Caffeic acid
O OH
OH
HO
0.625 0.625 0.625 1.25 5 5
Ellagic acid
O
O
O
O
OH
OH
HO
HO
1.25 5 5 5 >5 >5
Gallic acid
O
OH
OH
HO
HO
0.0098 0.0039 0.0195 0.039 0.00975 0.0039
Kaempferol
O
O
OH
OH
HO
HO
>5 >5 >5 >5 >5 >5
Quercetin O
O OH
OH
OH
HO
HO
>5 >5 >5 >5 >5 >5
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Table 1: Continued.
(mg⋅mL−1) Chemical structure
S. epidermidis S. aureus K. pneumoniae
MIC MBC MIC MBC MIC MBC
Rutin OO
O
O
OO
OH
OH
OH
OH
OH
HO
HO
HO
HO
HO
>5 >5 >5 >5 >5 >5
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Figure 2: Values of the halo dimension (disk diffusion assay) for
each extract (5mg⋅mL−1) for the 3 bacteria. The halo size was
calculated by deducting the size of the disk (0.6 cm). Ca: caffeic acid;
Ea: ellagic acid; Ga: gallic acid; K: kaempferol; Q: quercetin; and R:
rutin.
and MBC for quercetin of 10mg⋅mL−1 for the same bacteria,
which corroborates our results. In this case, the differences
among results can be justified by the methods used. For
instance, Fattouch et al. [25] used the microdilution method,
the same procedure used in this work; however, El-Gammal
andMansour [26] used a method dependent on the diffusion
capacity of the compounds which justify the differences on
the MIC of the quercetin. In the case of rutin, some authors
described that 0.5 or 4mg⋅mL−1 [27, 28] was enough to
destroy all cells of S. aureus, but our results suggest that rutin
is not capable of reducing the total number of viable cells
of S. aureus for concentrations under 5mg⋅mL−1. Bisignano
et al. [27] obtained the MIC of rutin by the macrodilution
method and, also, the phenolic compound was dissolved in
DMSO;Orhan et al. [28] used themicrodilution test, but they
dissolved the rutin in ethanol-hexanol. In both situations,
the MIC values described may be due to the solvents used
for rutin dissolution and, also, the MBC should be assessed
as a complementary method.
Concerning the phenolic acids tested, ellagic acid was
not able to inhibit the growth of the 3 bacteria used,
although its MIC for S. epidermidis was 1.25mg⋅mL−1. The
ellagic acid has been described as antibacterial agent and its
mechanism of action is related to the capacity to interact
with enzymes, inhibiting their action and interactions with
proteins [29]. Ohemeng et al. [30] showed that the MIC of
the ellagic acid against the bacteria S. epidermidis and S.
aureus was 0.125mg⋅mL−1 and Thiem and Gos´lin´ska [31],
besides MIC, also determined the MCB of this phenolic acid
against the same bacteria and reported the values of 0.63 and
2.5mg⋅mL−1, respectively.
In the literature, the gallic acid and the caffeic acid
showed the same antibacterial mechanism, related to their
similar structure (Table 1).These phenolic acids disrupted the
bacteria cell by hyperacidification of the plasma membrane
via proton donation and acidification of the intracellular
cytosolic; this low pH can inhibit the enzyme H+-ATPase
necessary for the ATP production [32–34]. Our results
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demonstrated that the gallic acid and the caffeic acid had
effect against the 3 bacteria tested. However, the first phenolic
was active against both Gram-positive and Gram-negative
bacteria with concentration on the range of 𝜇g⋅mL−1 and the
caffeic acid activity was only detected when concentrations
between 0.625 and 5mg⋅mL−1 were used. Moreover, the K.
pneumoniae was the most resilient bacteria to the caffeic acid
(Table 1).
Most of the published works regarding the antibacterial
activity of gallic and caffeic acids use the disk diffusion assay
method without any quantitative analysis for complementary
analysis [32, 35–37]. This which may lead to misleading
results related to the capacity of these molecules to diffuse
into the solid medium. Regarding the caffeic acid activity,
Kwon et al. reported formation of halo when in contact with
Gram-positive and Gram-negative bacteria for 50mg⋅mL−1
[32, 37]. Gutie´rrez-Larraı´nzar et al. [35] obtained a MIC
value for S. aureus of 561 𝜇g⋅mL−1 of gallic acid and Binutu
and Cordell [38] had a MIC of 250𝜇g⋅mL−1, 10 and 7 times
higher, respectively, than the value attained in this work
despite of the fact that method used was the same. The
differences of the MIC value may rely on lower temperature
(35∘C instead of 37∘C) used for the growth of S. aureus by
Gutie´rrez-Larraı´nzar et al. [35] or in a misleading caused by
the colouration of the gallic acid [19].
The differences found on the results published may be
due to the diverse methods applied in each work to assess
the MIC and MBC and/or interferences on the MIC and
MBC procedure, such as variations on the volume and
concentration inoculum, source of the flavonoid (natural or
commercial), salts formation, and precipitation leading to
misleading results [19].
3.3. Effect of Gallic and Caffeic Acid on 3T3 Fibroblast Growth
and Adhesion. Besides the antibacterial activity of natural
molecules, the knowledge of their effect on the human cells
is also crucial. Therefore, to predict the effects of the most
promising phenolic compounds (gallic and caffeic acid) on
animal cells, a preliminary assay of cytotoxicity was made.
The gallic acid showed no toxicity to the fibroblast when
concentrations between 0.01 and 0.1mg⋅mL−1 were used
(Figure 3(a)). In fact, the lowest concentration induced an
increase on the number of viable cellsmeasured.However, for
concentrations above 0.1mg⋅mL−1, gallic acid became toxic.
The effect of caffeic acid on the viability of cells was
dose dependent. The caffeic had no significant influence
on the cells growth for concentrations between 0.06 and
1.26mg⋅mL−1, but a reduction greater than 30% of viability
was measured when 6.31mg⋅mL−1, or higher, was applied.
Both phenolic compounds have been described as potent
antioxidant, and as consequence they exert some chemo-
preventive effects on animal cells [39, 40]. However, their
antioxidant activity is based on oxidation-reduction reac-
tions that are reversible and dependent on concentration.
Therefore, these phenolics can act both as antioxidant and
prooxidant, depending on the reaction conditions [39, 41].
This explains the fact that for higher concentrations gal-
lic and caffeic acids induce major reduction on the cells
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Figure 3:The viability of cells after 24 h of contactwith gallic acid (a)
and caffeic acid (b) dissolved in PBS, measured with an MTS assay.
All data is expressed as mean + standard deviation (𝑛 = 9). The line
indicates 70% of cell viability; when higher values were obtained the
compound was considered nontoxic to the cells.
viability. Additionally, gallic acid was more toxic, since
less than 20% of cells were capable of surviving for the
concentrations between 0.5 and 1mg⋅mL−1 (Figure 3(a)). For
the same range of the concentrations, the cells tolerated
the caffeic acid (Figure 3(b)). Our findings corroborate the
fact that the predisposition to act as prooxidant is directly
proportional to the number of hydroxyl groups in the
molecule; gallic acid has 4 hydroxyl groups and caffeic only 3
(Table 1).
Nerveless, the gallic acid can be used as antibacterial
agent against the bacteria tested without causing any damage
to the animal cells, since its MBC was 0.04mg⋅mL−1 and
at this range of concentrations the percentage of viable
cells measured was higher than 70%; above this limit the
compounds are safe for humans based on the ISO 10993-
5:2006. In the case of caffeic acid, the concentration capable
of destroying all the bacteria was, also, toxic to the fibroblast,
which may suggest that the mechanism involved on the
antibacterial action is the same as one that causes damage to
animal cells.
4. Conclusion
The results presented in this work highlight the potential
of phenolic extracts from wild northeast Portuguese plants
as antibacterial agents, as well as some of their phenolic
compounds.
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Overall, extracts from Cistus ladanifer, Cytisus multi-
florus,Castanea sativa, Filipendula ulmaria, andRosamicran-
tha were capable of inhibiting the growth of the 3 bac-
teria commonly isolated from skin and soft tissue infec-
tions.Moreover,Cistus ladanifer,Castanea sativa, Filipendula
ulmaria, and Rosa micrantha revealed promising antibac-
terial effects against K. pneumoniae, S. epidermidis, and S.
aureus, in concentrations between 0.625 and 2.5mg⋅mL−1.
From those extracts, 6 phenolic compounds were
selected. The flavonoids (kaempferol, quercetin, and rutin)
were capable of inducing halo formation on Gram-positive
bacteria. However, the quantitative assay of the flavonoids
demonstrated that they were not active for concentrations
below 5mg⋅mL−1. Regarding the phenolic acids, the ellagic
acid was only active against S. epidermidis, but gallic and
caffeic acids showed good antibacterial activity against the 3
bacteria at low concentrations.Thus, their effect on fibroblast
proliferation was assessed and revealed that caffeic acid has
dose-response cytotoxicity and can be considered safe for
concentrations less than 6.31mg⋅mL−1. Regarding gallic acid,
at the lowest concentration it promoted the proliferation
of fibroblast but for concentrations above 0.1mg⋅mL−1 it
became toxic. Nevertheless, conjugating the antibacterial and
cytotoxicity results, it could be pointed out that gallic acid
can be used safely presenting antibacterial activity against
the 3 bacteria.
Therefore, the present work pretends to be a starting
point to the use of phenolic compounds from northeastern
Portugal plants on the treatment of infected wounds, instead
of large-spectrum antibiotics.
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